Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Regulators Enforcing More Post-Market Surveillance (Part 1 of 2)

This article was originally published in PharmAsia News

Executive Summary

TOKYO - As Japan looks to resolve its drug lag with the West, pharmaceutical companies are finding more and more "all cases surveillance" requirements added as conditions for approval by Japan's Ministry of Health, Labor and Welfare

You may also be interested in...



Japan’s PDMA Shifts Post-heparin Focus Of GMP Inspections Onto Asia

Japan's Pharmaceutical and Medical Device Agency will focus inspections for compliance with good manufacturing practices predominantly on Asian countries, the agency's inspection specialist, Ryoko Naruse, said during an Osaka seminar

Japan’s PDMA Shifts Post-heparin Focus Of GMP Inspections Onto Asia

Japan's Pharmaceutical and Medical Device Agency will focus inspections for compliance with good manufacturing practices predominantly on Asian countries, the agency's inspection specialist, Ryoko Naruse, said during an Osaka seminar

Pharmacovigilance Is A Global Safety Issue – DIA Singapore Conference

Pharmacovigilance and risk management is a global safety issue, and the quality of safety data that is being retrieved is more important than where the data is coming from, according to consultant and former U.S. FDA MedWatch Medical Director Stephen Goldman

UsernamePublicRestriction

Register

RS009715

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel